There are 2934 resources available
Host tissue determinants of tumour immunity
Presenter: Cliona O'Farrelly
Session: Organ-specific immunity and cancer
Resources:
Slides
Webcast
Tissue-specific immune memory: The role of tissue-resident T-cells in cancer
Presenter: Eric Tartour
Session: Organ-specific immunity and cancer
Resources:
Slides
Webcast
Welcome and introduction
Presenter: Nadia Harbeck
Session: Novartis - Optimising patient outcomes and quality of life in HR+, HER2– ABC
Resources:
Webcast
Perspectives on the growing evidence for CDK4/6 inhibitors
Presenter: Lesley Fallowfield
Session: Novartis - Optimising patient outcomes and quality of life in HR+, HER2– ABC
Resources:
Webcast
Panelists
Presenter: Yen-Shen Lu
Session: Novartis - Optimising patient outcomes and quality of life in HR+, HER2– ABC
Resources:
Webcast
Emerging role of biomarker-driven therapy with PI3K inhibitors
Presenter: Lesley Fallowfield
Session: Novartis - Optimising patient outcomes and quality of life in HR+, HER2– ABC
Resources:
Webcast
Panelists
Presenter: Nadia Harbeck
Session: Novartis - Optimising patient outcomes and quality of life in HR+, HER2– ABC
Resources:
Webcast
Does radiotherapy still have a role in stage III NSCLC in the era of immunotherapy? The radiotherapist’s view
Presenter: Kevin Franks
Session: Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Resources:
Slides
Webcast
Where is immunotherapy for small cell lung cancer and mesothelioma now?
Presenter: Alessandra Curioni
Session: Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Resources:
Slides
Webcast
Insights in the biology and pathological diagnosis of thyroid malignancies
Presenter: Kate Newbold
Session: Recent advances in thyroid cancer
Resources:
Slides
Webcast